Tag: Orchestra BioMed
Orchestra BioMed secures additional capital from funding partners
Orchestra BioMed has secured US$70 million in new capital from Ligand Pharmaceuticals and Medtro...
Virtue trial to compare sirolimus and paclitaxel DCB technologies
Orchestra BioMed Holdings has announced that the US Food and Drug Administration (FDA) has approved ...
Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra BioMed enter global strategic partnership
Orchestra BioMed and Terumo have formed a global strategic partnership for the development and comme...
